|

INT230-6 Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Swiss Cancer Institute1
  • Intensity Therapeutics, Inc.1

Indications

  • Cancer2
  • Sarcoma,Soft Tissue1
  • TNBC - Triple-Negative Breast Cancer1
  • Triple Negative Breast Cancer1
  • Breast Cancer1

Other1 trial

Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
Phase 2

Los Angeles, California1 trial

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

USC/Norris Comprehensive Cancer Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.